Strs Ohio decreased its holdings in shares of Metlife Inc (NYSE:MET) by 1.3% during the third quarter, according to its most recent filing with the SEC. The firm owned 847,743 shares of the financial services provider’s stock after selling 10,853 shares during the period. Strs Ohio’s holdings in Metlife were worth $39,979,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Kavar Capital Partners LLC acquired a new stake in Metlife in the 2nd quarter worth approximately $25,000. Motco boosted its stake in Metlife by 160.6% in the 2nd quarter. Motco now owns 516 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 318 shares in the last quarter. Coastal Capital Group Inc. acquired a new stake in Metlife in the 2nd quarter worth approximately $30,000. Meeder Asset Management Inc. boosted its stake in Metlife by 2,474.2% in the 2nd quarter. Meeder Asset Management Inc. now owns 798 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 767 shares in the last quarter. Finally, Clean Yield Group boosted its stake in Metlife by 3,681.8% in the 2nd quarter. Clean Yield Group now owns 832 shares of the financial services provider’s stock worth $41,000 after purchasing an additional 810 shares in the last quarter. 75.60% of the stock is currently owned by institutional investors and hedge funds.
Shares of NYSE MET opened at $46.22 on Tuesday. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.22. The stock has a market cap of $43.17 billion, a price-to-earnings ratio of 8.57, a PEG ratio of 0.97 and a beta of 1.12. The company has a 50 day simple moving average of $46.31 and a two-hundred day simple moving average of $47.22. Metlife Inc has a 12 month low of $37.76 and a 12 month high of $51.16.
A number of analysts recently commented on the stock. Morgan Stanley lowered their target price on shares of Metlife from $54.00 to $53.00 and set an “equal weight” rating for the company in a research note on Tuesday, August 20th. B. Riley restated a “neutral” rating on shares of Metlife in a research note on Tuesday, October 15th. Wells Fargo & Co lifted their price objective on shares of Metlife from $55.00 to $57.00 and gave the company an “outperform” rating in a research note on Thursday, July 11th. ValuEngine cut shares of Metlife from a “sell” rating to a “strong sell” rating in a research note on Monday. Finally, Zacks Investment Research upgraded shares of Metlife from a “sell” rating to a “hold” rating and set a $51.00 price objective for the company in a research note on Friday, August 2nd. Two analysts have rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the stock. Metlife has a consensus rating of “Hold” and an average target price of $49.51.
Metlife Company Profile
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Featured Story: Penny Stocks
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.